High Death Rate Linked to Trasylol

October 11, 2013

Important Information

Attorneys working with ClassAction.org are no longer reviewing claims for this case. The information here is for reference only. A list of open investigations can be viewed here.

Comments |

At A Glance

This Alert Affects
Individuals who were given Trasylol to prevent excessive blood loss during coronary artery graft bypass surgery and suffered serious side effects may be able to recover compensation.
Damages
Trasylol side effects include serious kidney failure, congestive heart failure, stroke, death, pulmonary embolism, and renal failure.
Company(ies)
Bayer
Additional Details
Trasylol is a drug that is injected to prevent excessive blood loss during heart bypass surgery. Its works by slowing down fibrinolysis, the process that leads to the breakdown of blood clots. Use of this drug is intended to decrease the need for blood transfusions during surgery.
Date
A Trasylol warning was issued in December 2006 and it was permanently recalled in May 2008.